Clinical Trial Update: Adjuvant Use of Neostigmine in Sepsis and Septic Shock. [Phase 2]

View source ↗

Summary

A Phase 2 trial led by Mansoura University evaluating adjuvant neostigmine for sepsis and septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Neostigmine (neostigmine)

Snippet

Sponsor: Mansoura University | Conditions: Sepsis, Septic Shock | Phase 2 | Status: COMPLETED